NEWEarnings
iBio (IBIO) Stock Initiated at Buy with $7 Target
Published on Β· Source: investing.com
AI Summary
Summarized by AI from the source belowH.C. Wainwright has initiated coverage of iBio (IBIO) with a 'buy' rating and a price target of $7. This rating suggests a positive outlook for the stock, indicating potential for growth. Analysts see value in the company, likely based on its business strategies or recent developments. Investors may find this significant as the price target implies a favorable return if met.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Understand this kind of story
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Related News
Earnings
Connect Biopharma Stock Rated Buy at $7 by H.C. Wainwright
Sep 17
Earnings
Generac (GNRC) Stock Rating Reiterated by Jefferies on Amazon Partnership
Sep 17
Earnings
Kodiak Sciences Stock Rating Reiterated by H.C. Wainwright
Sep 17
Earnings
Goldman Sachs Downgrades Fluence Energy Stock Rating Outlook
Sep 17